These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 29104025)

  • 21. Immune approaches to the treatment of breast cancer, around the corner?
    Criscitiello C; Esposito A; Gelao L; Fumagalli L; Locatelli M; Minchella I; Adamoli L; Goldhirsch A; Curigliano G
    Breast Cancer Res; 2014 Feb; 16(1):204. PubMed ID: 25774617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in breast cancer immunotherapy: The promising impact of nanomedicines.
    Hashemzadeh N; Dolatkhah M; Adibkia K; Aghanejad A; Barzegar-Jalali M; Omidi Y; Barar J
    Life Sci; 2021 Apr; 271():119110. PubMed ID: 33513401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive and prognostic significance of tumor-infiltrating lymphocytes in patients with breast cancer treated with neoadjuvant systemic therapy.
    Melichar B; Študentova H; Kalábová H; Vitásková D; Čermáková P; Hornychová H; Ryška A
    Anticancer Res; 2014 Mar; 34(3):1115-25. PubMed ID: 24596349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy in Breast Cancer.
    Marmé F
    Oncol Res Treat; 2016; 39(6):335-45. PubMed ID: 27260697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integration of radiation and immunotherapy in breast cancer - Treatment implications.
    Ye JC; Formenti SC
    Breast; 2018 Apr; 38():66-74. PubMed ID: 29253718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumors with high-density tumor infiltrating lymphocytes constitute a favorable entity in breast cancer: a pooled analysis of four prospective adjuvant trials.
    Kotoula V; Chatzopoulos K; Lakis S; Alexopoulou Z; Timotheadou E; Zagouri F; Pentheroudakis G; Gogas H; Galani E; Efstratiou I; Zaramboukas T; Koutras A; Aravantinos G; Samantas E; Psyrri A; Kourea H; Bobos M; Papakostas P; Kosmidis P; Pectasides D; Fountzilas G
    Oncotarget; 2016 Jan; 7(4):5074-87. PubMed ID: 26506242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Which future for B lymphocytes infiltrating solid tumors: prognostic biomarker and/or therapeutic target?].
    Kaplon H; Dieu-Nosjean MC
    Med Sci (Paris); 2018 Jan; 34(1):72-78. PubMed ID: 29384099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA methylation-based immune response signature improves patient diagnosis in multiple cancers.
    Jeschke J; Bizet M; Desmedt C; Calonne E; Dedeurwaerder S; Garaud S; Koch A; Larsimont D; Salgado R; Van den Eynden G; Willard Gallo K; Bontempi G; Defrance M; Sotiriou C; Fuks F
    J Clin Invest; 2017 Aug; 127(8):3090-3102. PubMed ID: 28714863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of tumour-infiltrating lymphocytes in small HER2-positive breast cancer.
    Criscitiello C; Bagnardi V; Pruneri G; Vingiani A; Esposito A; Rotmensz N; Curigliano G
    Eur J Cancer; 2017 Dec; 87():164-171. PubMed ID: 29154173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer and immunology: biomarker and therapeutic developments.
    Santa-Maria CA; Park SJ; Jain S; Gradishar WJ
    Expert Rev Anticancer Ther; 2015; 15(10):1215-22. PubMed ID: 26358181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunotherapy for breast cancer: past, present, and future.
    Spellman A; Tang SC
    Cancer Metastasis Rev; 2016 Dec; 35(4):525-546. PubMed ID: 27913998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant Setting.
    Carbognin L; Pilotto S; Nortilli R; Brunelli M; Nottegar A; Sperduti I; Giannarelli D; Bria E; Tortora G
    Oncologist; 2016 Mar; 21(3):283-91. PubMed ID: 26865589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy in Breast Cancer: the Emerging Role of PD-1 and PD-L1.
    Bertucci F; Gonçalves A
    Curr Oncol Rep; 2017 Aug; 19(10):64. PubMed ID: 28799073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor infiltrating lymphocytes in early breast cancer.
    Pruneri G; Vingiani A; Denkert C
    Breast; 2018 Feb; 37():207-214. PubMed ID: 28363679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-infiltrating lymphocytes are associated with β-catenin overexpression in breast cancer.
    Ma X; Zhao X; Yan W; Yang J; Zhao X; Zhang H; Hui Y; Zhang S
    Cancer Biomark; 2018 Feb; 21(3):639-650. PubMed ID: 29286921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic and predictive immune gene signatures in breast cancer.
    Bedognetti D; Hendrickx W; Marincola FM; Miller LD
    Curr Opin Oncol; 2015 Nov; 27(6):433-44. PubMed ID: 26418235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy.
    Page DB; Yuan J; Redmond D; Wen YH; Durack JC; Emerson R; Solomon S; Dong Z; Wong P; Comstock C; Diab A; Sung J; Maybody M; Morris E; Brogi E; Morrow M; Sacchini V; Elemento O; Robins H; Patil S; Allison JP; Wolchok JD; Hudis C; Norton L; McArthur HL
    Cancer Immunol Res; 2016 Oct; 4(10):835-844. PubMed ID: 27587469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy strategies in the treatment of breast cancer.
    Soliman H
    Cancer Control; 2013 Jan; 20(1):17-21. PubMed ID: 23302903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immuno-oncology-101: overview of major concepts and translational perspectives.
    Allard B; Aspeslagh S; Garaud S; Dupont FA; Solinas C; Kok M; Routy B; Sotiriou C; Stagg J; Buisseret L
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):1-11. PubMed ID: 29428479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunotherapeutic options on the horizon in breast cancer treatment.
    van Rooijen JM; Stutvoet TS; Schröder CP; de Vries EG
    Pharmacol Ther; 2015 Dec; 156():90-101. PubMed ID: 26388292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.